UBS Group
EW icon

UBS Group’s Edwards Lifesciences EW Stock Holding History

UBS Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4M Buy
129,800
+2,000
+2% +$165K ﹤0.01% 3298
2025
Q4 		$10.9M Sell
127,800
-110,200
-46% -$9.04M ﹤0.01% 3198
2025
Q3 		$18.5M Buy
238,000
+111,100
+88% +$8.68M ﹤0.01% 2658
2025
Q2 		$9.92M Buy
126,900
+36,900
+41% +$2.75M ﹤0.01% 3088
2025
Q1 		$6.52M Sell
90,000
-73,900
-45% -$5.29M ﹤0.01% 3510
2024
Q4 		$12.1M Buy
163,900
+73,900
+82% +$5.17M ﹤0.01% 2847
2024
Q3 		$5.94M Buy
90,000
+15,000
+20% +$1.09M ﹤0.01% 2895
2024
Q2 		$6.93M Buy
75,000
+30,000
+67% +$2.66M ﹤0.01% 2540
2024
Q1 		$4.3M Sell
45,000
-30,000
-40% -$2.52M ﹤0.01% 3128
2023
Q4 		$5.72M Buy
75,000
+45,000
+150% +$3.13M ﹤0.01% 2656
2023
Q3 		$2.08M Buy
+30,000
New +$2.41M ﹤0.01% 3407
2020
Q2 		– Sell
-83,100
Closed -$5.22M – 8041
2020
Q1 		$5.22M Hold
83,100
– – ﹤0.01% 1878
2019
Q4 		$6.46M Buy
+83,100
New +$6.49M ﹤0.01% 2352
2016
Q4 		– Sell
-86,400
Closed -$3.47M – 7831
2016
Q3 		$3.47M Hold
86,400
– – ﹤0.01% 2372
2016
Q2 		$2.87M Buy
+86,400
New +$2.96M ﹤0.01% 2465
2015
Q2 		– Sell
-76,800
Closed -$1.82M – 8581
2015
Q1 		$1.82M Buy
76,800
+74,400
+3,100% +$1.67M ﹤0.01% 3015
2014
Q4 		$51K Buy
+2,400
New +$48.2K ﹤0.01% 6456

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS Group's EW Position: Q1 2026 in Review

UBS Group increased its Edwards Lifesciences (EW) stake by 57% in Q1 2026, buying an estimated $76.8M and bringing the position to 2,561,776 shares worth $205M. The position accounts for 0.03% of the portfolio, ranked #605.

UBS Group first reported a position in EW in Q4 2014 and has held it in 46 quarters since. The position peaked at $371M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • UBS Group held 2,561,776 shares of Edwards Lifesciences worth $205M as of Q1 2026.
  • UBS Group bought 931,016 Edwards Lifesciences shares in Q1 2026, an estimated $76.8M.
  • Edwards Lifesciences made up 0.03% of UBS Group's portfolio in Q1 2026, its #605 holding.
  • UBS Group first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Edwards Lifesciences position peaked at $371M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.